Search
for
Sort by
Research 181–210 of 1000+
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- A Comprehensive Bibliometric Analysis of Global Research Trends in Hair Loss Treatment: Key Contributions, Emerging Hotspots, and Future Directions
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- A Case Study on Exploring Immune Dysregulation in Alopecia Areata - Mechanisms and Treatments Outcomes
- Successful treatment of resistant alopecia totalis with tofacitinib
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Efficacy and Safety of Tofacitinib in Paediatric Alopecia Aerata - A Prospective Observational Study
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Quoi de neuf en dermatologie pédiatrique ?
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology)